Homocysteine, the kidney, and vascular disease Moderate differences in homocysteine concentrations do not cause vascular disease

Homocysteine, the kidney, and vascular disease Moderate differences in homocysteine concentrations do not cause vascular disease

Bibliográfalaš dieđut
Váldodahkkit:	Haynes, R, Clarke, R
Materiálatiipa:	Journal article
Almmustuhtton:	2012

Geahča maid

Homocysteine, the kidney, and vascular disease.
Dahkki: Haynes, R, et al.
Almmustuhtton: (2012)

Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials
Dahkki: Clarke, R, et al.
Almmustuhtton: (2011)

Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.
Dahkki: Clarke, R, et al.
Almmustuhtton: (2011)

Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis.
Dahkki: Clarke, R, et al.
Almmustuhtton: (2007)

Homocysteine and cardiovascular disease. Overview.
Dahkki: Clarke, R
Almmustuhtton: (1998)

Homocysteine and coronary heart disease.
Dahkki: Clarke, R, et al.
Almmustuhtton: (2002)

Homocysteine, B vitamins, and the risk of cardiovascular disease.
Dahkki: Clarke, R
Almmustuhtton: (2011)

Homocysteine and prediction of coronary heart disease and stroke
Dahkki: Clarke, R, et al.
Almmustuhtton: (2003)

Homocysteine, renal function, and risk of cardiovascular disease.
Dahkki: Clarke, R, et al.
Almmustuhtton: (2003)

Homocysteine and risk of cardiovascular disease and venous thrombosis
Dahkki: Clarke, R, et al.
Almmustuhtton: (2003)

Homocysteine, B-vitamins, and the risk of cardiovascular disease.
Dahkki: Clarke, R, et al.
Almmustuhtton: (2005)

Homocysteine-lowering trials for prevention of heart disease and stroke.
Dahkki: Clarke, R
Almmustuhtton: (2005)

Homocysteine-lowering And Cardiovascular Disease: Is The Door Closing Now
Dahkki: Clarke, R
Almmustuhtton: (2009)

Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
Dahkki: Clarke, R, et al.
Almmustuhtton: (2007)

Vascular Homocysteine vs 5-Methyl-Tetrahydrofolate as Regulators of Vascular Redox and Endothelial Function in Human Vessels
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2008)

Vascular Homocysteine Versus 5-Methyl-Tetrahydrofolate As Regulators of Vascular Redox and Endothelial Function in Human Vessels
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2009)

Homocysteine, B vitamins, and cardiovascular disease
Dahkki: Refsum, H, et al.
Almmustuhtton: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
Dahkki: Refsum, H, et al.
Almmustuhtton: (2006)

Commentary: an updated review of the published studies of homocysteine and cardiovascular disease.
Dahkki: Clarke, R
Almmustuhtton: (2002)

The hordaland homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease
Dahkki: Refsum, H, et al.
Almmustuhtton: (2006)

Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
Dahkki: Clarke, R, et al.
Almmustuhtton: (1998)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
Dahkki: Oulhaj, A, et al.
Almmustuhtton: (2010)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease
Dahkki: Oulhaj, A, et al.
Almmustuhtton: (2010)

Homocysteine, B vitamins, and the risk of dementia.
Dahkki: Clarke, R
Almmustuhtton: (2007)

Homocysteine: a risk factor for coronary artery disease?
Dahkki: Marinou, K, et al.
Almmustuhtton: (2005)

Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study.
Dahkki: Nurk, E, et al.
Almmustuhtton: (2005)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
Dahkki: Holman, R, et al.
Almmustuhtton: (2001)

Variability and determinants of total homocysteine concentrations in plasma in an elderly population.
Dahkki: Clarke, R, et al.
Almmustuhtton: (1998)

Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease.
Dahkki: van Meurs, J, et al.
Almmustuhtton: (2013)

Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
Dahkki: Clarke, R, et al.
Almmustuhtton: (2001)

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.
Dahkki: Clarke, R, et al.
Almmustuhtton: (1998)

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.
Dahkki: Collaboration, H
Almmustuhtton: (2002)

Analytical determination of homocysteine: a review.
Dahkki: Nekrassova, O, et al.
Almmustuhtton: (2003)

Betaine concentration as a determinant of fasting total homocysteine concentrations and the effect of folic acid supplementation on betaine concentrations.
Dahkki: Melse-Boonstra, A, et al.
Almmustuhtton: (2005)

Homocysteine and dementia – an international consensus statement
Dahkki: Smith, DA, et al.
Almmustuhtton: (2018)

Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies.
Dahkki: Danesh, J, et al.
Almmustuhtton: (1998)

Assessment of homocysteine as a cardiovascular risk factor in clinical practice.
Dahkki: Clarke, R, et al.
Almmustuhtton: (2001)

LC-MS/MS Analysis Of Plasma Homocysteine And Investigation On The Association Of Homocysteine Levels With Diabetic Peripheral Neuropathy
Dahkki: Lim, Luen Hui
Almmustuhtton: (2015)

Homocysteine, B vitamins, and cognitive impairment
Dahkki: Smith, A, et al.
Almmustuhtton: (2016)

Homocysteine lowering: any use in atherosclerosis?
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2007)